Embedded Files
Biopanda offers a range of COVID-19 Antibody Rapid Tests for the qualitative detection of antibodies to SARS-CoV-2 in human whole blood, serum or plasma. Designed for professional use, these rapid serological tests provide convenient solutions for investigating the antibody response to SARS-CoV-2 infection or vaccination. The range includes COVID-19 IgG/IgM antibody testing and an RBD IgG antibody test, providing flexible options for healthcare professionals, clinical laboratories, research applications and serological epidemiological investigations.
Covid-19 IgG/IgM Ab Rapid Test Kit
Covid-19 IgG/IgM Ab Rapid Test Kit
Catalogue Number: RAPG-COV-019
Kit Size: 10 Tests
Assay Time: 5-10 minutes
Storage: 2-30°C
Specimen: Whole Blood/Serum/Plasma
Results: Read visually
Description:
The Biopanda COVID-19 IgM/IgG Rapid Test Kit is a qualitative lateral flow immunochromatographic assay for the detection of IgM and IgG neutralising antibodies to SARS-CoV-2 in human whole blood, serum or plasma samples.
It is intended as a tool for carrying out serological epidemiological investigations. It is also intended for use as a tool to assist in the diagnosis of SARS-CoV-2 infections, in conjunction with other tests.
Covid-19 RBD IgG Ab Rapid Test Kit
Covid-19 RBD IgG Ab Rapid Test Kit
Catalogue Number: RAPG-COV-019R
Kit Size: 10 Tests
Assay Time: 5-10 minutes
Storage: 2-30°C
Specimen: Whole Blood/Serum/Plasma
Results: Read visually
Description:
The Biopanda COVID-19 RBD IgG Rapid Test Kit is a highly sensitive qualitative lateral flow immunochromatographic assay for the detection of anti-receptor binding domain (RBD) IgG neutralising antibodies to SARS-CoV-2 in human whole blood, serum or plasma samples.
This test is intended for the detection of antibodies generated by vaccination. It is also intended as a tool for carrying out serological epidemiological investigations.
Why Test for COVID-19 Antibodies?
Why Test for COVID-19 Antibodies?
Following exposure to SARS-CoV-2, the immune system can produce antibodies against specific viral proteins. Antibodies can also develop in response to COVID-19 vaccination. Testing for these antibodies can provide useful information about the immune response to SARS-CoV-2.
Unlike antigen tests, which are designed to detect components of the virus associated with current infection, COVID-19 antibody tests detect the immune response to SARS-CoV-2. Antibody testing can therefore be useful for applications such as serological investigations and studies of previous exposure or vaccine-induced antibody responses.
Different antibody targets can provide different information depending on the testing application. IgG and IgM antibody testing can be used as part of SARS-CoV-2 serological investigations, while testing for antibodies against the receptor binding domain (RBD) of the SARS-CoV-2 spike protein can be used to investigate antibody responses following vaccination.
Biopanda's COVID-19 Antibody Rapid Tests provide qualitative detection of SARS-CoV-2 antibodies in human whole blood, serum or plasma, with visually read results in 5–10 minutes. These tests provide convenient tools for professional serological testing, with results interpreted according to the intended use of the individual assay and alongside other appropriate clinical or laboratory information.
How to order:
Via the contact us page, fill in the form with all the necessary details and we will email you back ASAP.
Or, email us directly for general queries (please include the product catalogue number in the subject line, if applicable).
Page updated
Google Sites
Report abuse